Policy
-
Rethinking Access to Disability BenefitsAdvances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments.
by Jen Tota McGivney
-
April 30: The Week in Cancer NewsPresident Biden resurfaces a proposal for a new health care agency, and the Food and Drug Administration approves a treatment for large B-cell lymphoma.
by Bradley Jones
-
Forward Look
Making Cancer Clinical Trials More InclusiveDespite efforts by policymakers, a gender gap persists in clinical trial participation.
by Lindsey Konkel
-
Policy Matters
Research Advocacy During COVID-19Continued federal funding to support biomedical research, including cancer research, is vitally important during the pandemic.
by Brandon Leonard, MA, and Marc Johnson, MPP
-
Q&A
Up for DebateHematologist-oncologist Vinayak K. Prasad describes his positions on cancer research and policy in a recently published book.
by Marci A. Landsmann
-
Immunotherapy Options for Breast CancerTwo immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
Cancer and COVID-19 VaccinationAmid continued research showing the impact of COVID-19 on people with cancer, patients are asking when they should get a COVID-19 vaccine.
by Marci A. Landsmann
-
Colorectal Cancer Screenings at HomeStool-based tests could increase access to colorectal cancer screening.
by Jen Tota McGivney
-
Policy Matters
Cancer Scientists Support COVID-19 ResponseResearchers study ways to improve telehealth capabilities, clinical trials and health disparities.
by Trevan Locke, PhD
-
Forward Look
Creating More Inclusive Clinical TrialsThe Clinical Treatment Act aims to include more Medicaid recipients.
by Jen Tota McGivney
